DK
Dillip Kumar Tripathy
About Dillip Kumar Tripathy
Data last updated:
Dillip Kumar Tripathy is a Managing Director at Real Future Pharmaceuticals Private Limited (since 2021) and Director at Aadiom International Private Limited (since 2025). The companies operate in Chemicals and Pharma. The largest current company by reported revenue is Real Future Pharmaceuticals Private Limited at ₹39.1 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Real Future Pharmaceuticals Private Limited U24200OR2021PTC036065 | Managing Director | 31 Mar 2021 | 2021 | ₹39.1 Lakh (FY 2025) | Active |
| Aadiom International Private Limited U46497HP2025PTC011593 | Director | 11 Apr 2025 | 2025 | Active |
Board colleagues of Dillip Kumar Tripathy
| Name | DIN | Company | Designation |
|---|---|---|---|
| Madhabananda Mahapatra | 11050713 | Real Future Pharmaceuticals Private Limited , Aadiom International Private Limited | Director |
| Sasmita Tripathy | 09130326 | Real Future Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Dillip Kumar Tripathy
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dillip Kumar Tripathy
Dillip Kumar Tripathy currently holds 2 directorships: Real Future Pharmaceuticals Private Limited (Managing Director, since 31 Mar 2021, revenue ₹39.1 Lakh (FY 2025)); Aadiom International Private Limited (Director, since 11 Apr 2025).
Dillip Kumar Tripathy was first appointed on 31 Mar 2021 as Managing Director at Real Future Pharmaceuticals Private Limited. The most recent appointment on record is 11 Apr 2025 at Aadiom International Private Limited.
The current boards of Dillip Kumar Tripathy's companies include Madhabananda Mahapatra (Real Future Pharmaceuticals Private Limited), Sasmita Tripathy (Real Future Pharmaceuticals Private Limited).